JP2024504504A5 - - Google Patents
Info
- Publication number
- JP2024504504A5 JP2024504504A5 JP2023546404A JP2023546404A JP2024504504A5 JP 2024504504 A5 JP2024504504 A5 JP 2024504504A5 JP 2023546404 A JP2023546404 A JP 2023546404A JP 2023546404 A JP2023546404 A JP 2023546404A JP 2024504504 A5 JP2024504504 A5 JP 2024504504A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- strand
- compound
- rna
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163143805P | 2021-01-30 | 2021-01-30 | |
| US63/143,805 | 2021-01-30 | ||
| US202163262315P | 2021-10-08 | 2021-10-08 | |
| US63/262,315 | 2021-10-08 | ||
| US202163271683P | 2021-10-25 | 2021-10-25 | |
| US63/271,683 | 2021-10-25 | ||
| PCT/EP2022/052069 WO2022162154A1 (en) | 2021-01-30 | 2022-01-28 | Conjugated oligonucleotide compounds, methods of making and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024504504A JP2024504504A (ja) | 2024-01-31 |
| JP2024504504A5 true JP2024504504A5 (https=) | 2025-01-27 |
Family
ID=81213673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546404A Pending JP2024504504A (ja) | 2021-01-30 | 2022-01-28 | コンジュゲートオリゴヌクレオチド化合物、その作製方法及び使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230310486A1 (https=) |
| EP (1) | EP4175964A1 (https=) |
| JP (1) | JP2024504504A (https=) |
| AU (1) | AU2022215065B2 (https=) |
| CA (1) | CA3204317A1 (https=) |
| WO (1) | WO2022162154A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3204340A1 (en) | 2021-01-30 | 2022-08-04 | Ahmad Ali MORTAZAVI | Conjugated oligonucleotide compounds, methods of making and uses thereof |
| ES3030929T3 (en) | 2022-12-19 | 2025-07-02 | Arnatar Therapeutics Inc | Arnatar compounds and methods for enhanced cellular uptake |
| CN118356506A (zh) * | 2023-01-17 | 2024-07-19 | 中国科学院上海药物研究所 | 去唾液酸糖蛋白受体配体与细胞毒素的偶联物及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8273866B2 (en) | 2002-02-20 | 2012-09-25 | Merck Sharp & Dohme Corp. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA) |
| DE60310944T3 (de) | 2002-08-05 | 2017-08-03 | Silence Therapeutics Gmbh | Weitere neue formen von interferierende rns moleküle |
| US9150606B2 (en) | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| US9150605B2 (en) | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation |
| KR100576357B1 (ko) | 2003-10-21 | 2006-05-03 | 삼성전자주식회사 | 레졸을 함유하는 수지용액, 이를 사용하여 형성된열경화수지막 및 이를 사용하여 열경화수지막을 형성하는방법 |
| WO2009073809A2 (en) * | 2007-12-04 | 2009-06-11 | Alnylam Pharmaceuticals, Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| AU2009298802A1 (en) * | 2008-09-23 | 2010-04-08 | Alnylam Pharmaceuticals, Inc. | Chemical modifications of monomers and oligonucleotides with cycloaddition |
| DK2992098T3 (da) * | 2013-05-01 | 2019-06-17 | Ionis Pharmaceuticals Inc | Sammensætninger og fremgangsmåder til modulering af hbv- og ttr-ekspression |
| EP3564374A1 (en) * | 2013-06-21 | 2019-11-06 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulation of target nucleic acids |
| WO2015042447A1 (en) * | 2013-09-20 | 2015-03-26 | Isis Pharmaceuticals, Inc. | Targeted therapeutic nucleosides and their use |
| US10119136B2 (en) | 2014-01-09 | 2018-11-06 | Alnylam Pharmaceuticals, Inc. | RNAi agents modified at the 4′-C position |
| WO2018112320A1 (en) * | 2016-12-16 | 2018-06-21 | Alnylam Pharmaceuticals, Inc. | Methods for treating or preventing ttr-associated diseases using transthyretin (ttr) irna compositions |
| CN110268060B (zh) * | 2017-01-10 | 2024-07-26 | 箭头药业股份有限公司 | α-1抗胰蛋白酶(AAT)RNAi物质、包含AAT RNAi物质的组合物和使用方法 |
| AU2018213379A1 (en) * | 2017-01-30 | 2019-07-18 | Arrowhead Pharmaceuticals Inc. | Compositions and methods for inhibition of factor XII gene expression |
| EA202090720A1 (ru) * | 2017-09-14 | 2020-07-07 | Янссен Байофарма, Инк. | ПРОИЗВОДНЫЕ GalNAc |
| PE20211783A1 (es) * | 2018-11-08 | 2021-09-08 | Aligos Therapeutics Inc | Polimeros oligonucleotidos que inhiben el transporte de antigenos y metodos |
| EP3931323A4 (en) * | 2019-02-28 | 2023-04-05 | Deep Genomics Incorporated | LIGAND CLUSTER AND METHODS OF USE AND PRODUCTION THEREOF |
| EP3976788A1 (en) * | 2019-05-30 | 2022-04-06 | Deep Genomics Incorporated | Oligonucleotide therapy for wolman disease and cholesteryl ester storage disease |
| EP4176061A1 (en) * | 2021-01-30 | 2023-05-10 | E-Therapeutics plc | Nucleic acids containing abasic nucleotides |
-
2022
- 2022-01-28 JP JP2023546404A patent/JP2024504504A/ja active Pending
- 2022-01-28 CA CA3204317A patent/CA3204317A1/en active Pending
- 2022-01-28 WO PCT/EP2022/052069 patent/WO2022162154A1/en not_active Ceased
- 2022-01-28 EP EP22704512.7A patent/EP4175964A1/en active Pending
- 2022-01-28 AU AU2022215065A patent/AU2022215065B2/en active Active
-
2023
- 2023-02-06 US US18/106,158 patent/US20230310486A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024504504A5 (https=) | ||
| JP2024504505A5 (https=) | ||
| KR0155574B1 (ko) | 주쇄가 변성된 올리고뉴클레오티드 유사체 | |
| EP0541722B1 (en) | Compounds and methods for inhibiting gene expression | |
| KR100321416B1 (ko) | 2'-o-치환된 피리미딘 및 이들의 올리고머 화합물의 개선된 제조방법 | |
| JP2733777B2 (ja) | ２′，５′―ホスホロチオエ―トオリゴアデニレ―トおよびその抗ウィルス用途 | |
| JP3787265B2 (ja) | ２’−ｏ−置換ピリミジンおよびそのオリゴマー化合物の合成の改良法 | |
| CA2283509C (en) | Novel bicyclonucleoside and oligonucleotide analogue | |
| US5695979A (en) | Inhibition of reverse transcriptase by phosphorodithioates | |
| Shrestha et al. | Guanidine bridged nucleic acid (GuNA): an effect of a cationic bridged nucleic acid on DNA binding affinity | |
| JP2023068035A5 (https=) | ||
| JPH07505290A (ja) | オリゴヌクレオチドの合成 | |
| JPH07508042A (ja) | 新規２’−０−アルキルヌクレオシドおよびホスホロアミダイトの製造法およびその使用 | |
| JPH08508493A (ja) | ７−デアザプリン修飾オリゴヌクレオチド | |
| IE74705B1 (en) | Compounds and methods for inhibiting gene expression | |
| JP2022503850A5 (https=) | ||
| JPH08508490A (ja) | 新規５’−置換ヌクレオシド及びそれから得られるオリゴマー | |
| EP0290583A1 (fr) | OLIGONUCLEOTIDES -g(a). | |
| EP0701564A1 (en) | Bifunctional nucleosides, oligomers thereof, and methods of making and using the same | |
| JPH10504022A (ja) | 相補的ｄｎａ及びトキシン | |
| US6605708B1 (en) | Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom | |
| Fathi et al. | (Aminomethyl) phosphonate derivatives of oligonucleotides | |
| KR101117998B1 (ko) | 신규 2', 5'-올리고아데닐산 유사체 | |
| JP3142574B2 (ja) | ２′，５′ホスホロチオエート／ホスホジエステルオリゴアデニレートおよびその抗ウィルス用途 | |
| CA2216284A1 (en) | Thiono triester modified antisense oligodeoxynucleotide phosphorothioates |